Monogram Orthopaedics, Inc.
MGRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $365 | $0 | $628 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $430 | $0 | $387 | $459 |
| Gross Profit | -$430 | $365 | -$387 | $170 |
| % Margin | – | 100% | – | 27% |
| R&D Expenses | $8,790 | $10,586 | $4,973 | $5,279 |
| G&A Expenses | $4,412 | $4,053 | $2,926 | $1,897 |
| SG&A Expenses | $6,520 | $7,047 | $5,640 | $5,168 |
| Sales & Mktg Exp. | $2,108 | $2,994 | $2,714 | $3,272 |
| Other Operating Expenses | -$430 | $0 | $0 | $0 |
| Operating Expenses | $14,880 | $17,633 | $10,357 | $10,447 |
| Operating Income | -$15,310 | -$17,268 | -$10,613 | -$10,278 |
| % Margin | – | -4,731% | – | -1,635.9% |
| Other Income/Exp. Net | -$1,018 | $3,523 | -$3,078 | -$1,537 |
| Pre-Tax Income | -$16,328 | -$13,745 | -$13,691 | -$11,815 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$16,328 | -$13,745 | -$13,691 | -$11,815 |
| % Margin | – | -3,765.8% | – | -1,880.6% |
| EPS | -0.5 | -0.61 | -0.47 | -0.4 |
| % Growth | 18% | -29.8% | -17.5% | – |
| EPS Diluted | -0.5 | -0.61 | -0.47 | -0.4 |
| Weighted Avg Shares Out | 32,571 | 22,409 | 29,253 | 29,253 |
| Weighted Avg Shares Out Dil | 32,571 | 22,409 | 29,253 | 29,253 |
| Supplemental Information | – | – | – | – |
| Interest Income | $526 | $434 | $98 | $48 |
| Interest Expense | $0 | $0 | $0 | $22 |
| Depreciation & Amortization | $430 | $412 | $387 | $322 |
| EBITDA | -$15,898 | -$16,856 | -$10,226 | -$9,956 |
| % Margin | – | -4,618% | – | -1,584.7% |